A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A Disease
Identifieur interne : 001E13 ( Main/Exploration ); précédent : 001E12; suivant : 001E14A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A Disease
Auteurs : Kathryn M. Edwards [États-Unis] ; William D. Dupont [États-Unis] ; Mary K. Westrich [États-Unis] ; Walton D. Plummer [États-Unis] ; Pamela S. Palmer [États-Unis] ; Peter F. Wright [États-Unis]Source :
- Journal of Infectious Diseases [ 0022-1899 ] ; 1994.
Abstract
A double-blind, randomized controlled trial over 5 years compared the safety, immunogenicity, and efficacy of cold-adapted and inactivated influenza A vaccines in 5210 normal subjects. Both vaccines were well tolerated. Inactivated vaccine significantly increased hemagglutination inhibition antibody titers. Significant titer rises were also noted after cold-adapted vaccine but of lesser magnitude than with inactivated vaccine. The efficacyof inactivated vaccine in preventing culture-positive influenza was 76% (95% confidence interval [CI], 58%–87%) for HINI disease and 74% (95% CI, 52%–86%) for H3N2; for cold-adapted vaccine, 85% (95% CI, 70%–92%) and 58% (95% CI, 29%–75%), respectively. The efficacy of inactivated vaccine in preventing a four-fold rise in antibody titer over the influenza season was 69% (95% CI, 61%–76%) for H1N1 and 73% (95% CI, 65%–79%) for H3N2; for cold-adapted vaccine, 54% (95% CI, 44%–62%) and 32% (95% CI, 17%–44%), respectively. Cold-adapted and inactivated influenza vaccines are safe and effective for preventing influenza A disease.
Url:
DOI: 10.1093/infdis/169.1.68
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001249
- to stream Istex, to step Curation: 001249
- to stream Istex, to step Checkpoint: 000B84
- to stream Main, to step Merge: 001E95
- to stream Main, to step Curation: 001E13
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A Disease</title>
<author><name sortKey="Edwards, Kathryn M" sort="Edwards, Kathryn M" uniqKey="Edwards K" first="Kathryn M." last="Edwards">Kathryn M. Edwards</name>
</author>
<author><name sortKey="Dupont, William D" sort="Dupont, William D" uniqKey="Dupont W" first="William D." last="Dupont">William D. Dupont</name>
</author>
<author><name sortKey="Westrich, Mary K" sort="Westrich, Mary K" uniqKey="Westrich M" first="Mary K." last="Westrich">Mary K. Westrich</name>
</author>
<author><name sortKey="Plummer, Walton D" sort="Plummer, Walton D" uniqKey="Plummer W" first="Walton D." last="Plummer">Walton D. Plummer</name>
</author>
<author><name sortKey="Palmer, Pamela S" sort="Palmer, Pamela S" uniqKey="Palmer P" first="Pamela S." last="Palmer">Pamela S. Palmer</name>
</author>
<author><name sortKey="Wright, Peter F" sort="Wright, Peter F" uniqKey="Wright P" first="Peter F." last="Wright">Peter F. Wright</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:37F7982F82A9A7629574338CF256B0762EFC0757</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1093/infdis/169.1.68</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-BWV3WDKK-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001249</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001249</idno>
<idno type="wicri:Area/Istex/Curation">001249</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B84</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B84</idno>
<idno type="wicri:doubleKey">0022-1899:1994:Edwards K:a:randomized:controlled</idno>
<idno type="wicri:Area/Main/Merge">001E95</idno>
<idno type="wicri:Area/Main/Curation">001E13</idno>
<idno type="wicri:Area/Main/Exploration">001E13</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A Disease</title>
<author><name sortKey="Edwards, Kathryn M" sort="Edwards, Kathryn M" uniqKey="Edwards K" first="Kathryn M." last="Edwards">Kathryn M. Edwards</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Division of Pediatric Infectious Diseases, Department of Pediatrics, and Division of Biostatistics, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Reprints or correspondence: Dr. Kathryn M. Edwards, Division of Pediatric Infectious Diseases, Dept. of Pediatrics, D-7226 Medical Center N., Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Dupont, William D" sort="Dupont, William D" uniqKey="Dupont W" first="William D." last="Dupont">William D. Dupont</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Division of Pediatric Infectious Diseases, Department of Pediatrics, and Division of Biostatistics, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Westrich, Mary K" sort="Westrich, Mary K" uniqKey="Westrich M" first="Mary K." last="Westrich">Mary K. Westrich</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Division of Pediatric Infectious Diseases, Department of Pediatrics, and Division of Biostatistics, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Plummer, Walton D" sort="Plummer, Walton D" uniqKey="Plummer W" first="Walton D." last="Plummer">Walton D. Plummer</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Division of Pediatric Infectious Diseases, Department of Pediatrics, and Division of Biostatistics, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Palmer, Pamela S" sort="Palmer, Pamela S" uniqKey="Palmer P" first="Pamela S." last="Palmer">Pamela S. Palmer</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Division of Pediatric Infectious Diseases, Department of Pediatrics, and Division of Biostatistics, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Wright, Peter F" sort="Wright, Peter F" uniqKey="Wright P" first="Peter F." last="Wright">Peter F. Wright</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Division of Pediatric Infectious Diseases, Department of Pediatrics, and Division of Biostatistics, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Infectious Diseases</title>
<title level="j" type="abbrev">J Infect Dis.</title>
<idno type="ISSN">0022-1899</idno>
<idno type="eISSN">1537-6613</idno>
<imprint><publisher>The University of Chicago Press</publisher>
<date when="1994-01">1994</date>
<biblScope unit="vol">169</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="68">68</biblScope>
<biblScope unit="page" to="76">76</biblScope>
</imprint>
<idno type="ISSN">0022-1899</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-1899</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">A double-blind, randomized controlled trial over 5 years compared the safety, immunogenicity, and efficacy of cold-adapted and inactivated influenza A vaccines in 5210 normal subjects. Both vaccines were well tolerated. Inactivated vaccine significantly increased hemagglutination inhibition antibody titers. Significant titer rises were also noted after cold-adapted vaccine but of lesser magnitude than with inactivated vaccine. The efficacyof inactivated vaccine in preventing culture-positive influenza was 76% (95% confidence interval [CI], 58%–87%) for HINI disease and 74% (95% CI, 52%–86%) for H3N2; for cold-adapted vaccine, 85% (95% CI, 70%–92%) and 58% (95% CI, 29%–75%), respectively. The efficacy of inactivated vaccine in preventing a four-fold rise in antibody titer over the influenza season was 69% (95% CI, 61%–76%) for H1N1 and 73% (95% CI, 65%–79%) for H3N2; for cold-adapted vaccine, 54% (95% CI, 44%–62%) and 32% (95% CI, 17%–44%), respectively. Cold-adapted and inactivated influenza vaccines are safe and effective for preventing influenza A disease.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Tennessee</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Tennessee"><name sortKey="Edwards, Kathryn M" sort="Edwards, Kathryn M" uniqKey="Edwards K" first="Kathryn M." last="Edwards">Kathryn M. Edwards</name>
</region>
<name sortKey="Dupont, William D" sort="Dupont, William D" uniqKey="Dupont W" first="William D." last="Dupont">William D. Dupont</name>
<name sortKey="Edwards, Kathryn M" sort="Edwards, Kathryn M" uniqKey="Edwards K" first="Kathryn M." last="Edwards">Kathryn M. Edwards</name>
<name sortKey="Palmer, Pamela S" sort="Palmer, Pamela S" uniqKey="Palmer P" first="Pamela S." last="Palmer">Pamela S. Palmer</name>
<name sortKey="Plummer, Walton D" sort="Plummer, Walton D" uniqKey="Plummer W" first="Walton D." last="Plummer">Walton D. Plummer</name>
<name sortKey="Westrich, Mary K" sort="Westrich, Mary K" uniqKey="Westrich M" first="Mary K." last="Westrich">Mary K. Westrich</name>
<name sortKey="Wright, Peter F" sort="Wright, Peter F" uniqKey="Wright P" first="Peter F." last="Wright">Peter F. Wright</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E13 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E13 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:37F7982F82A9A7629574338CF256B0762EFC0757 |texte= A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A Disease }}
This area was generated with Dilib version V0.6.33. |